Hervolution pitch at Novo BII demo-day by Peter J. Holst

Hervolution treats cancer by target tumor virus within the human genome. In this video you can learn more about the company, where Hervolution is presented by Associate Professor Peter Johannes Holst.

Related news

Blog_post_2
971c7d753c56304e_800x800ar
_DSC2407final
MGT_JR_Coleman